Aeglea BioTherapeutics
a has emerged as one of the most promising targets in both and | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
31 of 56
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
September 2023
a has emerged as one of the most promising targets in both and | Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
a has emerged as one of the most promising targets in both and | Aeglea BioTherapeutics
Related slides by other companies
BioAtla
Investor Presentation
August 2023
encouraging phase results with | BioAtla
9 Meters Biopharma
Investor Presentation
September 2022
vibrant phase summary of results | 9 Meters Biopharma
Mondee
Investor Presentation
June 2023
chairman message | Mondee
ATAI
Investor Presentation
October 2023
in cash as of provides expected runway into life sciences operational focus program guidance | ATAI
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights